Hypertrophic and Keloid Scar Therapy Market Insights, Global Outlook and Forecast 2022-2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The scar is elevated above the skin and remains hyperemic. Excessive fibrous tissue is classified as either a keloid or a hypertrophic scar. Kischer and Brody declared the collagen nodule to be the identifying structural unit of hypertrophic scars and keloids.
The latest research study released by Market IntelliX evaluates market size and forecasts of Hypertrophic and Keloid Scar Therapy in global, including the following market information:
Global Hypertrophic and Keloid Scar Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hypertrophic and Keloid Scar Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hypertrophic and Keloid Scar Therapy companies in 2021 (%)
The global Hypertrophic and Keloid Scar Therapy market was valued at 6990.6 million in 2021 and is projected to reach US$ 11380 million by 2028, at a CAGR of 7.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Products Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hypertrophic and Keloid Scar Therapy include Smith & Nephew, Enaltus, Merz, Lumenis, Sonoma Pharmaceuticals, Cynosure, Scar Heal, Mölnlycke Health and Perrigo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Hypertrophic and Keloid Scar Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Hypertrophic and Keloid Scar Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hypertrophic and Keloid Scar Therapy Market Segment Percentages, by Type, 2021 (%)
Topical Products
Laser Products
Injectable
Others
Global Hypertrophic and Keloid Scar Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hypertrophic and Keloid Scar Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Hypertrophic and Keloid Scar Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hypertrophic and Keloid Scar Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypertrophic and Keloid Scar Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hypertrophic and Keloid Scar Therapy revenues share in global market, 2021 (%)
Key companies Hypertrophic and Keloid Scar Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hypertrophic and Keloid Scar Therapy sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Smith & Nephew
Enaltus
Merz
Lumenis
Sonoma Pharmaceuticals
Cynosure
Scar Heal
Mölnlycke Health
Perrigo
NewMedical Technology
Suneva Medical
Pacific World
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Hypertrophic and Keloid Scar Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypertrophic and Keloid Scar Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypertrophic and Keloid Scar Therapy Overall Market Size
2.1 Global Hypertrophic and Keloid Scar Therapy Market Size: 2021 VS 2028
2.2 Global Hypertrophic and Keloid Scar Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hypertrophic and Keloid Scar Therapy Sales: 2017-2028
3 Company Landscape
3.1 Top Hypertrophic and Keloid Scar Therapy Players in Global Market
3.2 Top Global Hypertrophic and Keloid Scar Therapy Companies Ranked by Revenue
3.3 Global Hypertrophic and Keloid Scar Therapy Revenue by Companies
3.4 Global Hypertrophic and Keloid Scar Therapy Sales by Companies
3.5 Global Hypertrophic and Keloid Scar Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hypertrophic and Keloid Scar Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hypertrophic and Keloid Scar Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hypertrophic and Keloid Scar Therapy Players in Global Market
3.8.1 List of Global Tier 1 Hypertrophic and Keloid Scar Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Hypertrophic and Keloid Scar Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hypertrophic and Keloid Scar Therapy Market Size Markets, 2021 & 2028
4.1.2 Topical Products
4.1.3 Laser Products
4.1.4 Injectable
4.1.5 Others
4.2 By Type - Global Hypertrophic and Keloid Scar Therapy Revenue & Forecasts
4.2.1 By Type - Global Hypertrophic and Keloid Scar Therapy Revenue, 2017-2022
4.2.2 By Type - Global Hypertrophic and Keloid Scar Therapy Revenue, 2023-2028
4.2.3 By Type - Global Hypertrophic and Keloid Scar Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Hypertrophic and Keloid Scar Therapy Sales & Forecasts
4.3.1 By Type - Global Hypertrophic and Keloid Scar Therapy Sales, 2017-2022
4.3.2 By Type - Global Hypertrophic and Keloid Scar Therapy Sales, 2023-2028
4.3.3 By Type - Global Hypertrophic and Keloid Scar Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Hypertrophic and Keloid Scar Therapy Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Hypertrophic and Keloid Scar Therapy Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Hypertrophic and Keloid Scar Therapy Revenue & Forecasts
5.2.1 By Application - Global Hypertrophic and Keloid Scar Therapy Revenue, 2017-2022
5.2.2 By Application - Global Hypertrophic and Keloid Scar Therapy Revenue, 2023-2028
5.2.3 By Application - Global Hypertrophic and Keloid Scar Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Hypertrophic and Keloid Scar Therapy Sales & Forecasts
5.3.1 By Application - Global Hypertrophic and Keloid Scar Therapy Sales, 2017-2022
5.3.2 By Application - Global Hypertrophic and Keloid Scar Therapy Sales, 2023-2028
5.3.3 By Application - Global Hypertrophic and Keloid Scar Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Hypertrophic and Keloid Scar Therapy Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Hypertrophic and Keloid Scar Therapy Market Size, 2021 & 2028
6.2 By Region - Global Hypertrophic and Keloid Scar Therapy Revenue & Forecasts
6.2.1 By Region - Global Hypertrophic and Keloid Scar Therapy Revenue, 2017-2022
6.2.2 By Region - Global Hypertrophic and Keloid Scar Therapy Revenue, 2023-2028
6.2.3 By Region - Global Hypertrophic and Keloid Scar Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Hypertrophic and Keloid Scar Therapy Sales & Forecasts
6.3.1 By Region - Global Hypertrophic and Keloid Scar Therapy Sales, 2017-2022
6.3.2 By Region - Global Hypertrophic and Keloid Scar Therapy Sales, 2023-2028
6.3.3 By Region - Global Hypertrophic and Keloid Scar Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hypertrophic and Keloid Scar Therapy Revenue, 2017-2028
6.4.2 By Country - North America Hypertrophic and Keloid Scar Therapy Sales, 2017-2028
6.4.3 US Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.4.4 Canada Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.4.5 Mexico Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hypertrophic and Keloid Scar Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Hypertrophic and Keloid Scar Therapy Sales, 2017-2028
6.5.3 Germany Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.5.4 France Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.5.5 U.K. Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.5.6 Italy Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.5.7 Russia Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.5.9 Benelux Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hypertrophic and Keloid Scar Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Hypertrophic and Keloid Scar Therapy Sales, 2017-2028
6.6.3 China Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.6.4 Japan Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.6.5 South Korea Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.6.7 India Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hypertrophic and Keloid Scar Therapy Revenue, 2017-2028
6.7.2 By Country - South America Hypertrophic and Keloid Scar Therapy Sales, 2017-2028
6.7.3 Brazil Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.7.4 Argentina Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hypertrophic and Keloid Scar Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hypertrophic and Keloid Scar Therapy Sales, 2017-2028
6.8.3 Turkey Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.8.4 Israel Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
6.8.6 UAE Hypertrophic and Keloid Scar Therapy Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Smith & Nephew
7.1.1 Smith & Nephew Corporate Summary
7.1.2 Smith & Nephew Business Overview
7.1.3 Smith & Nephew Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.1.4 Smith & Nephew Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Smith & Nephew Key News
7.2 Enaltus
7.2.1 Enaltus Corporate Summary
7.2.2 Enaltus Business Overview
7.2.3 Enaltus Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.2.4 Enaltus Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Enaltus Key News
7.3 Merz
7.3.1 Merz Corporate Summary
7.3.2 Merz Business Overview
7.3.3 Merz Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.3.4 Merz Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Merz Key News
7.4 Lumenis
7.4.1 Lumenis Corporate Summary
7.4.2 Lumenis Business Overview
7.4.3 Lumenis Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.4.4 Lumenis Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Lumenis Key News
7.5 Sonoma Pharmaceuticals
7.5.1 Sonoma Pharmaceuticals Corporate Summary
7.5.2 Sonoma Pharmaceuticals Business Overview
7.5.3 Sonoma Pharmaceuticals Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.5.4 Sonoma Pharmaceuticals Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Sonoma Pharmaceuticals Key News
7.6 Cynosure
7.6.1 Cynosure Corporate Summary
7.6.2 Cynosure Business Overview
7.6.3 Cynosure Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.6.4 Cynosure Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Cynosure Key News
7.7 Scar Heal
7.7.1 Scar Heal Corporate Summary
7.7.2 Scar Heal Business Overview
7.7.3 Scar Heal Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.7.4 Scar Heal Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Scar Heal Key News
7.8 Mölnlycke Health
7.8.1 Mölnlycke Health Corporate Summary
7.8.2 Mölnlycke Health Business Overview
7.8.3 Mölnlycke Health Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.8.4 Mölnlycke Health Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Mölnlycke Health Key News
7.9 Perrigo
7.9.1 Perrigo Corporate Summary
7.9.2 Perrigo Business Overview
7.9.3 Perrigo Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.9.4 Perrigo Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Perrigo Key News
7.10 NewMedical Technology
7.10.1 NewMedical Technology Corporate Summary
7.10.2 NewMedical Technology Business Overview
7.10.3 NewMedical Technology Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.10.4 NewMedical Technology Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.10.5 NewMedical Technology Key News
7.11 Suneva Medical
7.11.1 Suneva Medical Corporate Summary
7.11.2 Suneva Medical Hypertrophic and Keloid Scar Therapy Business Overview
7.11.3 Suneva Medical Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.11.4 Suneva Medical Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Suneva Medical Key News
7.12 Pacific World
7.12.1 Pacific World Corporate Summary
7.12.2 Pacific World Hypertrophic and Keloid Scar Therapy Business Overview
7.12.3 Pacific World Hypertrophic and Keloid Scar Therapy Major Product Offerings
7.12.4 Pacific World Hypertrophic and Keloid Scar Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Pacific World Key News
8 Global Hypertrophic and Keloid Scar Therapy Production Capacity, Analysis
8.1 Global Hypertrophic and Keloid Scar Therapy Production Capacity, 2017-2028
8.2 Hypertrophic and Keloid Scar Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Hypertrophic and Keloid Scar Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hypertrophic and Keloid Scar Therapy Supply Chain Analysis
10.1 Hypertrophic and Keloid Scar Therapy Industry Value Chain
10.2 Hypertrophic and Keloid Scar Therapy Upstream Market
10.3 Hypertrophic and Keloid Scar Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hypertrophic and Keloid Scar Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Hypertrophic and Keloid Scar Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|